1. Home
  2. AKBA vs SCHL Comparison

AKBA vs SCHL Comparison

Compare AKBA & SCHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

HOLD

Current Price

$1.42

Market Cap

380.4M

Sector

Health Care

ML Signal

HOLD

Logo Scholastic Corporation

SCHL

Scholastic Corporation

HOLD

Current Price

$38.80

Market Cap

875.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKBA
SCHL
Founded
2007
1920
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Books
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
380.4M
875.2M
IPO Year
2014
1995

Fundamental Metrics

Financial Performance
Metric
AKBA
SCHL
Price
$1.42
$38.80
Analyst Decision
Strong Buy
Hold
Analyst Count
6
1
Target Price
$5.75
$40.00
AVG Volume (30 Days)
2.4M
482.4K
Earning Date
05-07-2026
03-19-2026
Dividend Yield
N/A
2.05%
EPS Growth
93.94
N/A
EPS
N/A
1.87
Revenue
N/A
$1,487,100,000.00
Revenue This Year
N/A
$1.81
Revenue Next Year
N/A
$4.23
P/E Ratio
N/A
$20.88
Revenue Growth
N/A
N/A
52 Week Low
$1.14
$15.77
52 Week High
$4.08
$39.65

Technical Indicators

Market Signals
Indicator
AKBA
SCHL
Relative Strength Index (RSI) 54.71 68.38
Support Level $1.30 $27.31
Resistance Level $1.55 $39.65
Average True Range (ATR) 0.07 1.10
MACD -0.00 0.31
Stochastic Oscillator 46.15 87.87

Price Performance

Historical Comparison
AKBA
SCHL

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.

About SCHL Scholastic Corporation

Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.

Share on Social Networks: